Advanced Technology and Analytical Methods for Assessing the Impact of Anticancer Drug Metabolites on Drug Efficacy and Toxicity

Shamim Akhtar, Shahbaz Hassan Mansoor, Saima Batool, Sumeet Dayyan and Sania Akbar
Additional contact information
Shamim Akhtar: National College of Business Administration and Economics, Pakistan
Shahbaz Hassan Mansoor: University of Education Lahore, Multan Campus, Pakistan
Saima Batool: Muhammad Nawaz Sharif University of Agricultural, Pakistan
Sumeet Dayyan: University of Central Punjab, Lahore, Pakistan
Sania Akbar: The Women University Multan, Pakistan

Bulletin of Business and Economics (BBE), 2024, vol. 13, issue 2, 884-892

Abstract: This study focuses on advancing the analysis of anticancer drug metabolites by integrating cutting-edge analytical and computational techniques. To improve the separation and identification of metabolites, we employ advanced chromatographic methods, including Ultra-Performance Liquid Chromatography (UPLC) coupled with high-resolution mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy. These techniques provide enhanced resolution and accuracy in metabolite profiling. Computational approaches, such as molecular dynamics (MD) simulations and quantum mechanical (QM) calculations, are utilized to predict metabolic pathways and identify novel metabolites, while quantitative structure-activity relationship (QSAR) models assess biological activity and potential toxicity. The study reveals that Metabolite A exhibits high binding affinity and favorable reaction energy, suggesting its significant role in drug efficacy, whereas Metabolite B, despite lower binding affinity, shows higher potency and may contribute substantially to therapeutic effects. In contrast, Metabolite C, with the lowest binding affinity and less favorable reaction energy, presents potential safety concerns. This integrated methodology highlights the importance of combining advanced analytical techniques with computational models to optimize drug development and personalized medicine. The findings underscore the potential for improved therapeutic efficacy and safety in oncology through detailed metabolite analysis.

Keywords: Anticancer drugs; metabolite analysis; high-resolution mass spectrometry; quantitative structure-activity relationship; Computational Modeling (search for similar items in EconPapers)
Date: 2024
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://bbejournal.com/BBE/article/view/922/952 (application/pdf)
https://bbejournal.com/index.php/BBE/article/view/922 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:rfh:bbejor:v:13:y:2024:i:2:p:884-892

DOI: 10.61506/01.00404

Access Statistics for this article

Bulletin of Business and Economics (BBE) is currently edited by Dr. Muhammad Irfan Chani

More articles in Bulletin of Business and Economics (BBE) from Research Foundation for Humanity (RFH) Contact information at EDIRC.
Bibliographic data for series maintained by Dr. Muhammad Irfan Chani ().